Nath Bio-Genes (India) Limited

NSE: NATHBIOGEN · Unclassified

₹137.43+0.49%06 Nov 2026

Ask the data

Instant answers about Nath Bio-Genes (India) Limited — computed from its filings, no language model

Market cap₹261 cr

Current price₹137.43

High / Low₹196 / ₹129

P/E—

P/B0.38

Book value₹358.1

ROE0.0%

ROCE7.4%

Debt / equity0.20

Dividend yield1.45%

EPS (TTM)₹0.00

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY26
Revenue	301.4	332.6	445.1
EBITDA	48.7	49.9	52.4
Operating margin	16.2%	15.0%	11.8%
Interest	10.1	9.1	16.0
Depreciation	3.0	3.3	4.0
Profit before tax	36.2	41.6	46.3
Tax	1.1	1.9	4.7
Net profit	35.0	0.0	0.0
EPS ₹	18.42	21.34	20.98
Operating cash flow	38.4	70.3	-12.6
Capex	2.5	8.4	3.0
Dividend paid	3.8	-3.8	3.8
Total assets	792.8	880.2	1,097.4
Equity	573.2	609.9	680.5

Quarterly performance

last 13 quarters · ₹ crore

showing latest 8 of 13 periods

	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	45.0	235.3	22.6	31.7	43.0	243.9	32.2	36.9	283.7	43.9	66.0	51.6	328.4
Operating profit	3.9	36.8	5.5	5.7	3.9	36.5	4.8	8.0	38.3	6.1	3.6	4.5	35.1
Operating margin	8.7%	15.6%	24.4%	17.8%	9.1%	15.0%	14.9%	21.8%	13.5%	13.9%	5.4%	8.7%	10.7%
Other income	0.3	0.1	0.1	0.0	0.4	0.1	0.1	0.5	1.8	1.9	1.7	2.4	1.9
Interest	1.5	2.8	2.4	2.8	1.1	2.2	3.0	3.9	3.2	3.7	4.5	4.6	4.3
Depreciation	1.0	0.8	0.8	0.8	1.0	0.8	0.8	0.8	1.0	1.0	1.0	1.0	1.0
Profit before tax	1.7	33.4	2.4	4.6	3.2	33.6	1.1	3.8	37.9	5.5	2.5	2.5	33.0
Tax	0.2	0.2	0.3	0.8	0.6	0.2	-0.0	1.1	0.7	0.6	0.9	2.5	0.7
Net profit	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0
EPS ₹	0.76	17.47	0.86	2.02	1.87	17.49	0.53	1.33	19.58	1.40	0.84	-0.79	16.98
Revenue YoY	—	—	—	—	-4.3%	3.7%	42.6%	16.2%	16.3%	36.2%	78.9%	—	15.8%
Profit YoY	—	—	—	—	-100.0%	—	—	—	—	—	-100.0%	—	—

Earlier results (standalone, Jun '13 – Dec '22)

₹ crore · from BSE, before the NSE XBRL filings begin

Nath Bio-Genes (India) Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†	FY22†
Revenue	189.4	185.3	162.1	169.7	191.7	230.9	279.9	307.6	278.4
Operating profit	33.4	37.6	24.5	28.8	40.4	44.2	54.7	66.7	37.2
Operating margin	17.6%	20.3%	15.1%	17.0%	21.1%	19.2%	19.5%	21.7%	13.4%
Other income	0.6	0.6	0.7	0.7	—	2.3	1.8	1.7	1.9
Interest	3.8	4.6	6.2	9.7	10.3	6.2	6.5	8.8	10.6
Depreciation	4.7	7.3	3.9	3.0	0.9	1.4	1.5	2.8	3.1
Profit before tax	25.5	26.2	15.1	16.8	30.1	38.9	48.5	56.8	-63.4
Tax	1.2	0.9	0.9	0.5	0.6	0.2	-2.0	1.1	4.0
Net profit	24.3	25.4	14.2	16.3	29.4	38.6	50.5	55.7	-67.3

Quarters

showing latest 8 of 39 periods

	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†
Revenue	103.3	19.5	26.2	40.4	119.5	30.1	26.3	9.5	106.5	4.0	23.3	28.3	84.3	16.4	18.2	50.8	101.5	14.4	25.8	50.0	127.0	23.8	27.9	52.3	165.3	21.4	33.1	60.1	193.2	23.3	36.0	55.0	214.6	14.9	21.7	27.2	209.3	21.7	25.3
Operating profit	24.8	4.0	6.0	-1.4	32.2	3.9	4.8	-3.4	26.8	-3.4	3.8	-2.7	19.7	3.1	5.2	0.7	23.4	6.5	6.9	3.6	27.3	5.1	6.0	5.8	36.9	5.3	5.7	6.7	43.8	5.4	6.4	11.1	48.1	4.4	6.0	-21.3	34.4	4.8	5.6
Operating margin	24.0%	20.3%	23.0%	-3.5%	27.0%	12.9%	18.4%	-35.7%	25.2%	-86.1%	16.3%	-9.4%	23.4%	19.1%	28.7%	1.4%	23.0%	45.0%	26.8%	7.3%	21.5%	21.6%	21.4%	11.1%	22.3%	25.0%	17.2%	11.2%	22.7%	23.2%	17.7%	20.2%	22.4%	29.7%	27.7%	-78.1%	16.5%	21.9%	22.2%
Other income	0.1	0.1	0.1	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.3	0.1	0.0	—	0.8	0.7	0.8	0.4	0.4	0.6	0.3	0.4	0.5	0.4	0.5	0.9	-0.1	0.5	0.4	0.3	0.7	0.0	0.2	0.1
Interest	0.7	0.7	1.5	0.9	1.0	1.8	0.9	0.9	1.7	2.5	1.4	0.7	2.3	1.8	2.6	2.9	2.9	2.7	2.7	2.0	1.1	2.0	1.7	1.4	1.7	1.5	1.6	1.7	2.0	2.0	2.1	2.7	2.7	2.8	2.7	2.5	2.9	2.8	3.0
Depreciation	1.2	1.2	1.2	0.9	1.1	1.1	3.6	1.4	1.1	1.2	1.6	0.0	1.0	0.8	0.9	0.4	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.3	0.7	0.7	0.7	0.8	0.7	0.7	0.7	1.1	0.7	0.7	0.7
Profit before tax	22.9	2.1	3.4	-2.9	30.2	1.0	0.6	-5.5	24.0	-6.8	0.8	-2.9	16.5	0.8	1.8	-2.3	20.5	3.6	4.0	2.0	26.5	3.6	4.3	4.5	35.5	3.8	4.1	5.2	41.5	3.2	4.5	7.5	45.2	1.3	2.9	-112.8	30.9	1.5	2.0
Tax	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.7	0.0	0.0	0.6	-0.1	0.3	0.1	0.0	0.3	0.5	0.0	0.8	-1.0	0.2	0.1	0.2	-2.5	0.3	0.1	0.3	0.3	0.3	0.1	0.1	3.5	0.2	0.1	0.7
Net profit	22.9	2.1	3.4	-4.1	30.2	1.0	0.6	-6.4	24.0	-6.9	0.6	-3.6	16.5	0.8	1.2	-2.2	20.2	3.6	4.0	1.7	26.0	3.6	3.5	5.5	35.3	3.7	3.9	7.6	41.3	3.0	4.2	7.1	44.9	1.2	2.8	-116.3	30.8	1.5	1.4
EPS ₹	14.31	1.31	2.13	-2.56	18.88	0.63	0.35	-4.02	15.02	-4.29	0.36	-2.24	10.31	0.50	0.73	-1.36	12.61	2.22	2.47	0.92	13.69	1.90	1.84	2.90	18.55	1.94	2.05	3.78	21.71	1.59	2.23	3.76	23.63	0.65	1.48	-61.19	16.18	0.77	0.71
Revenue YoY	—	—	—	—	15.6%	54.2%	0.3%	-76.6%	-10.8%	-86.9%	-11.4%	199.0%	-20.9%	316.5%	-22.1%	79.5%	20.4%	-12.5%	41.9%	-1.5%	25.1%	65.3%	8.1%	4.6%	30.2%	-10.2%	18.6%	15.0%	16.9%	8.9%	9.0%	-8.5%	11.1%	-36.1%	-39.9%	-50.5%	-2.5%	46.2%	16.8%
Profit YoY	—	—	—	—	31.9%	-51.9%	-83.2%	—	-20.4%	-780.2%	1.8%	—	-31.4%	—	101.7%	—	22.4%	345.0%	237.6%	—	28.9%	1.4%	-11.4%	216.1%	35.6%	2.2%	11.4%	38.7%	17.0%	-18.4%	9.0%	-6.4%	8.8%	-59.1%	-33.9%	-1728.7%	-31.5%	19.5%	-52.0%

Returns & margins

trailing-twelve-month, per quarter

	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '26	JUN '26
ROE	0.2%	0.0%	0.0%	0.0%	0.4%	0.0%	0.0%
ROCE	7.2%	7.4%	7.3%	6.7%	6.8%	7.9%	7.4%
Net margin	0.4%	0.0%	0.0%	0.0%	0.7%	0.0%	0.0%
EBITDA margin	15.5%	15.6%	15.1%	14.5%	15.0%	11.8%	10.1%
Debt / equity	0.19	0.17	0.17	0.20	0.20	0.20	0.20
Interest coverage	5.39	5.79	6.10	5.66	5.09	4.03	3.55
Asset turnover	0.40	0.38	0.39	0.42	0.43	0.41	0.45

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '23	SEP '23	MAR '24	SEP '24	SEP '25	MAR '26
Share capital	19.0	19.0	19.0	19.0	19.0	19.0
Other equity / reserves	554.2	585.0	590.9	621.3	660.9	661.5
Total equity	573.2	604.0	609.9	640.3	679.9	680.5
Borrowings	105.2	112.8	105.5	127.5	154.8	138.5
Current liabilities	216.4	239.4	262.4	181.3	316.6	394.7
Non-current liabilities	3.2	3.3	7.9	6.9	17.7	22.3
Total assets	792.8	846.8	880.2	828.5	1,014.2	1,097.4
Property, plant & equipment	234.0	233.8	240.7	243.0	243.1	243.8
Capital work-in-progress	0.0	0.0	0.0	0.0	0.0	0.0
Investments	5.0	5.0	8.8	6.0	5.8	5.9
Inventories	207.8	162.7	230.3	167.1	308.0	450.6
Receivables	97.3	219.0	94.3	147.7	179.3	85.4
Cash & equivalents	38.0	15.2	77.4	2.1	0.7	76.0

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY26
Cash from operations	38.4	70.3	-12.6
Cash from investing	-2.9	-27.4	3.5
Cash from financing	-1.7	-4.5	-3.8
Capex	2.5	8.4	3.0
Free cash flow	35.8	61.9	-15.6
Dividends paid	3.8	-3.8	3.8

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹243.8 cr22%

Investments

₹5.9 cr1%

Inventories

₹450.6 cr41%

Receivables

₹85.4 cr8%

Cash & equivalents

₹76.0 cr7%

Other assets

₹235.8 cr21%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Nath Bio-Genes (India) Limited	261	137.43	—	0.38	0.0%

StoxGud checklist: Bearish setup · 3/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+0.4%

6 months-21.2%

1 year-18.8%

3Y CAGR-9.8%

5Y CAGR-14.4%

10Y CAGR-3.3%

50-day avg₹142.52

200-day avg₹154.11

RSI (14)49

FAQs

What is the share price of Nath Bio-Genes (India) Limited?

Nath Bio-Genes (India) Limited (NATHBIOGEN) closed at ₹137.43 on NSE on 06 Nov 2026.

What is the market cap of Nath Bio-Genes (India) Limited?

₹261 crore at the latest close.

How fast is Nath Bio-Genes (India) Limited growing?

Nath Bio-Genes (India) Limited: Latest-quarter revenue is up 15.8% year on year.

How profitable is Nath Bio-Genes (India) Limited?

On a trailing-twelve-month basis return on equity is 0.0%, return on capital employed 7.4%, operating margin 10.1%, net margin 0.0%.

How much debt does Nath Bio-Genes (India) Limited have?

Nath Bio-Genes (India) Limited is lightly geared: debt to equity is 0.20 with borrowings of ₹138 cr against cash of ₹76 cr (balance sheet of 2026-03-31). Operating profit covers interest 3.5 times.

Financials parsed from Nath Bio-Genes (India) Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '23, annual from FY23, balance sheet from Mar '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.